Alendronate Sodium Tablets

CAS: 121268-17-5
Molecular Formula: C4H12NNaO7P2·3H2O
Molecular Weight: 325.12
Product description:Is the world's most widely used osteoporosis drug resistance, is listed in the United States in 1993, significantly increased in patients with bone mineral density, to reduce the risk of fractures, osteoporosis is first-line treatment drugs. Allen phosphonic acid sodium amino phosphonic acid salt of bone resorption inhibitor, and bone hydroxyapatite has a strong affinity, can enter the bone matrix hydroxyapatite crystal, when osteoclast dissolved crystals, the drug is released, can inhibit osteoclast activity, and inhibiting bone resorption by osteoblasts indirect effect, has a strong resistance to bone resorption activity, no bone mineralization characteristics of inhibition.